Watson Pharma Profile
Key Indicators
- Authorised Capital ₹ 200.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 161.98 Cr
as on 24-10-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 25.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 8.60 Cr
as on 24-10-2024
- Revenue 38.90%
(FY 2023)
- Profit 88.83%
(FY 2023)
- Ebitda 43.90%
(FY 2023)
- Net Worth 10.52%
(FY 2023)
- Total Assets 12.92%
(FY 2023)
About Watson Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 200.00 Cr and a paid-up capital of Rs 161.98 Cr.
The company currently has active open charges totaling ₹25.00 Cr. The company has closed loans amounting to ₹8.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Watson Pharma Private Limited India is Vivek Saraf as COMPANY SECRETARY. Hemant Mamania, Nishank Bhargava, and Agnieszka Lubkowska serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC156968
- Company No.
156968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2005
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Watson Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Saraf  | Company Secretary | 24-Nov-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishank Bhargava | Director | 24-Feb-2022 | Current |
| Hemant Mamania | Director | 03-Jan-2022 | Current |
| Agnieszka Lubkowska | Director | 18-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Watson Pharma.
Watson Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.9% increase. The company also saw a substantial improvement in profitability, with a 88.83% increase in profit. The company's net worth Soared by an impressive increase of 10.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Watson Pharma?
In 2023, Watson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Teva Pharmaceutical And Chemical Industries India Private Limited
Active 21 years 6 monthsNishank Bhargava is a mutual person
Actavis Pharma Development Centre Private Limited
Active 18 years 3 monthsNishank Bhargava is a mutual person
Teva Global Business Services Private Limited
Active 20 years 3 monthsNishank Bhargava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Jun 2009 | ₹25.00 Cr | Open |
Standard Chartered Bank Creation Date: 29 Nov 2005 | ₹8.00 M | Satisfied |
Standard Chartered Bank Creation Date: 23 Aug 2005 | ₹8.00 M | Satisfied |
How Many Employees Work at Watson Pharma?
Watson Pharma has a workforce of 1125 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Watson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Watson Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
